Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Gynecol Oncol. 2021 Feb 2;161(1):113–121. doi: 10.1016/j.ygyno.2021.01.025

Figure 2: Tumors with mutant TP53 have worse outcomes as compared to tumors with WT TP53.

Figure 2:

Kaplan-Meier survival plots of (A) PFS and (B) OS when all eligible cases on GOG-86P were subanalyzed by TP53 mutational status.